OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2024
(2)
2023
(2)
2026
(1)
2022
(1)
2021
(1)
2020
(1)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: Population-based cross-sectional surveys.
Not available
S-EPMC11004668
|
biostudies-literature
Cite
Mechanistic insights into dual-active liver and blood-stage antiplasmodials.
Not available
S-EPMC12802172
|
biostudies-literature
Cite
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
Not available
S-EPMC7005751
|
biostudies-literature
Cite
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers.
Not available
S-EPMC10497190
|
biostudies-literature
Cite
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients.
Not available
S-EPMC8554488
|
biostudies-literature
Cite
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial.
Not available
S-EPMC11058726
|
biostudies-literature
Cite
Off-target effects of bacillus Calmette-Guerin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19.
Not available
S-EPMC9028103
|
biostudies-literature
Cite
Setting research priorities to improve global newborn health and prevent stillbirths by 2025.
Not available
S-EPMC4576458
|
biostudies-literature
Cite
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets